For Immediate Release. Jan. 11, 2021. Bozeman, MT. Nanovalent Pharmaceuticals has been selected to present at the 2021 Biotech Showcase, a premier investor conference held each year during the week of the JP Morgan Healthcare Investment Week. This year, the conferences will be...

San Francisco (California) January 6, 2020: NanoValent Pharmaceuticals, Inc., a development stage, cancer focused pharmaceutical company progressing a new class of targeted nanosphere therapeutics, today announced the publication of United States Patent No. 10,369,104 from the...

NanoValent continues to progress towards its goal of moving our lead drug candidate to an IND/BLA and the clinic in 2021 and 2022. Although our “almost virtual” infrastructure has us sheltering-in-place as a regular course of business, these are by no means normal times.  Yet,...